on 17 Dec 2024
Last Applicant/ Owned by
200 Smith Street
Waltham
MA
02451
Serial Number
98322374 filed on 19th Dec 2023
Registration Number
N/A
Correspondent Address
Karen Won
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and Read More
Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors
N/A
N/A
No 98322374
No Service/Collective Mark
No 062902-400
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
17th Dec 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
17th Dec 2024 | PUBLISHED FOR OPPOSITION |
11th Dec 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
16th Oct 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
16th Oct 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
15th Oct 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
15th Oct 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
23rd Jul 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
23rd Jul 2024 | NON-FINAL ACTION WRITTEN |
23rd Jul 2024 | NON-FINAL ACTION E-MAILED |